期刊文献+

β3肾上腺素受体调节肝细胞核因子活性促进肝细胞载脂蛋白A-Ⅰ基因的转录

β3-AR promotes apoA-Ⅰgene transcription by regulating nuclear factor activity in hepatocytes
下载PDF
导出
摘要 目的探讨β3肾上腺素受体(β3-AR)对肝细胞载脂蛋白A-Ⅰ(apoA-Ⅰ)基因转录的调控作用。方法不同浓度(10^-5~10^-10 mol/L)β3-AR激动剂(BRL37344)和拮抗剂(SR59230A)分别孵育HepG2细胞,CCK8检测细胞活性。将HepG2细胞分为对照组、激动剂组(10^-6 mol/L的BRL37344)和拮抗剂组(10^-7 mol/L的SR59230A),孵育6 h;RT-qPCR检测apoA-ⅠmRNA表达;ELISA检测细胞外基质apoA-Ⅰ分泌水平;染色质免疫共沉淀联合RT-PCR检测肝细胞核因子(HNF)-4和HNF-3及早期生长反应蛋白1(EGR-1)。结果HepG2细胞在10^-6~10^-8 mol/L的BRL37344和SR59230A区间内生长增殖良好,孵育6 h和24 h时细胞呈现较高活性。与对照组比较,激动剂组肝细胞apoA-ⅠmRNA和细胞外基质apoA-Ⅰ分泌水平上调[2.9±0.5 vs 1.0±0.2,(590.1±54.6)μg/ml vs(395.5±23.4)μg/ml,P<0.01],且HNF-4和HNF-3结合活性显著升高(90.4±13.4 vs 17.2±1.2,78.3±20.6 vs 19.7±2.5,P<0.01)。3组肝细胞EGR-1结合活性比较,无统计学差异(P>0.05)。结论激活β3-AR使肝细胞HNF-4和HNF-3活性增高,可能是β3-AR上调肝脏apoA-Ⅰ转录水平的分子机制之一。 Objective To study the role ofβ3-AR in regulating apoA-Ⅰgene transcription in hepatocytes.Methods HepG2 cells were incubated withβ3-AR agonist(BRL37344)and antagonist(SR59230A)at the concentrations of 10^-5 mol/L and 10^-10 mol/L.The HepG2 cells were divided into control group(cell culture medium),agonist group(10^-6 mol/L BRL37344),antagonist group(10^-7 mol/L SR59230A).After the HepG2 cells were incubated for 6 h,the apoA-ⅠmRNA expression was detected by RT-qPCR,the apoA-Ⅰsecretion volume was measured by ELISA,the expressions of HNF-4,HNF-3 and EGR-1 were detected by RT-PCR.Results The growth and proliferation of HepG2 cells were quite good in 10^-6 mol/L of BRL37344 and in 10^-8 mol/L of SR59230A.The activity of HepG2 cells was quite high after the HepG2 cells were incubated for 6 h and 24 h.The apoA-ⅠmRNA expression level was significantly higher(2.9±0.5 vs 1.3±0.4,P<0.01),the apoA-Ⅰsecretion volume was significantly larger in agonist group than in antagonist group(P<0.01).The binding activity of HNF-4 and HNF-3 was significantly higher in agonist group than in antagonist group(P<0.01).No significant difference was detected in binding activity of EGR-1 among the 3 groups(P>0.05).Conclusion Activation ofβ3-AR can increase the activity of HNF-3 and HNF-4 in hepatocytes,which is one of the molecular mechanisms ofβ3-AR in upregulating the apoA-Ⅰgene transcription.
作者 曹晓菁 李艳芳 金泽宁 Cao Xiaojing;Li Yanfang;Jin Zening(Center for Cardiology,Affiliated Beijing Tiantan Hospital of Capital Medical University,Beijing 100070,Chian)
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2019年第9期971-975,共5页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 载脂蛋白A-Ⅰ 受体 肾上腺素能β3 转录因子 apolipoprotein A-Ⅰ receptors,adrenergic,beta-3 transcription factors
  • 相关文献

参考文献1

二级参考文献43

  • 1Tan S, Curtis-Prior PB. Characterization of the beta-adrenoceptor of the adipose cell of the rat. Int J Obes 1983; 7: 409-14.
  • 2Grujic D, Susulic VS, Harper ME, Himms-Hagen J, Cunningham BA, Corkey BE, et a I. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem 1997; 272: 17686-93.
  • 3Chernogubova E, Cannon B, Bengtsson T. Norepinephrine increases glucose transport in brown adipocytes via beta3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology 2004:145: 269-80.
  • 4Collins S, Daniel KW. Rohlfs EM, Ramkumar V, Taylor IL, Gettys TW. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 1994; 8: 518-27.
  • 5Kato H, Ohue M, Kato K, Nomura A, Toyosawa K, Furutani Y, et al. Mechanism of amelioration of insulin resistance by beta3-adrenoceptor agonist AJ-9677 in the KK-Ay/Ta diabetic obese mouse model. Diabetes 2001; 50: 113-22.
  • 6Fu L, Isobe K, Zeng Q, Suzukawa K. Takekoshi K, Kawakami Y. The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice. Eur J Pharmacol 2008; 584: 202-6.
  • 7"Kim H, Pennisi PA, Gavrilova 0, Pack S, Jou W, Setser-Portas J, et al. Effect of adipocyte beta3-adrenergic receptor activation on the type2 diabetic MKR mice. Am J Physiol Endocrinol Metab 2006; 290: E1227-36.".
  • 8Corella D, Ordovas JM. The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis. Curr Atheroscler Rep 2004; 6: 186-96.
  • 9Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipo-protein E. Science 1992; 258: 468-71.
  • 10Friedewald WT, Levy Rl, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部